NCT05122585View on ClinicalTrials.gov

Magnetic Tracer in the Sentinel Node Procedure in Breast Cancer: the Non-radioactive Alternative for Radio-isotopes

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

February 9, 2022

Study Completion Date

February 9, 2022

Conditions
Breast Cancer
Interventions
PROCEDURE

MagSeed and MagTrace in breast cancer patiënts

Combining MagSeed and Magtracer to perform a wide local excision breast conserving surgery and sentinel node biopsy.

Trial Locations (1)

6162BG

Zuyderland Medical Center, Sittard

All Listed Sponsors
collaborator

Sysmex America, Inc.

INDUSTRY

lead

Zuyderland Medisch Centrum

OTHER

NCT05122585 - Magnetic Tracer in the Sentinel Node Procedure in Breast Cancer: the Non-radioactive Alternative for Radio-isotopes | Biotech Hunter | Biotech Hunter